Story perspectives

AI Boosts Cancer Diagnosis Amid Screening Participation Decline

9/6/2025

Summary

Story summary

A deep-learning algorithm shows over 90% accuracy in cancer diagnosis, demonstrating significant potential.
Korean research reveals a 10% drop in cancer screening participation due to population decline, highlighting primary care needs.
The One Cancer Voice coalition in England plans a National Cancer Plan targeting prevention and equitable treatment.
Humana Medicare Advantage members can now access the Cologuard Plus test, improving colorectal cancer screening accuracy.
Exact Sciences is committed to enhancing cancer diagnostics through ongoing investment in innovative testing solutions.

1 of 1

Story summary

A deep-learning algorithm shows over 90% accuracy in cancer diagnosis, demonstrating significant potential.
Korean research reveals a 10% drop in cancer screening participation due to population decline, highlighting primary care needs.
The One Cancer Voice coalition in England plans a National Cancer Plan targeting prevention and equitable treatment.
Humana Medicare Advantage members can now access the Cologuard Plus test, improving colorectal cancer screening accuracy.
Exact Sciences is committed to enhancing cancer diagnostics through ongoing investment in innovative testing solutions.